MPO is a protein that is usually present in healthy people’s plasma in very low concentrations, and levels are elevated in atherosclerotic diseases like acute coronary syndrome or those with metabolic syndrome, and it affects PON1 activity, decreasing its activity [37,38]. This evidence concerns the gene PON1 and metabolic syndrome.